CEL-SCI CORPORATION Increase (Decrease) Due from Officers and Stockholders
CEL-SCI CORPORATION (CVM) reported Increase (Decrease) Due from Officers and Stockholders of -$220.00 thousand for the 12-month period ending 2025-09-30, per its 10-K filed 2025-12-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseDueFromOfficersAndStockholders · last filed 2025-12-29
- CEL-SCI CORPORATION increase (decrease) due from officers and stockholders for the quarter ending 2024-09-30 was $0.00.
- CEL-SCI CORPORATION increase (decrease) due from officers and stockholders for fiscal 2025 was -$220.00K.
- CEL-SCI CORPORATION increase (decrease) due from officers and stockholders for fiscal 2024 was -$80.62K.
| Period end | Increase (Decrease) Due from Officers and Stockholders 3 month | Increase (Decrease) Due from Officers and Stockholders 9 month | Increase (Decrease) Due from Officers and Stockholders 12 month |
|---|---|---|---|
| 2025-09-30 | -$220.00K 10-K · filed 2025-12-29 | ||
| 2024-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-29 | -$80.62K 10-K · filed 2025-12-29 | |
| 2024-06-30 | -$80.62K 10-Q · filed 2024-08-14 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |